Founded in 1968, the University of Maryland Division of Transplantation has established a national reputation for research innovation, surgical superiority and above average patient outcomes.
The University of Maryland is home to a one of the busiest transplant programs in the country, performing more than 420 transplants each year, with expertise in abdominal and thoracic organ transplantation, including kidney, pancreas, liver, heart and lungs, and living donor kidney and adult living donor liver transplantation.
Transplant teams at the University of Maryland Medical Center work in multidisciplinary settings to leverage clinical and research expertise across the full spectrum of pre- and post-transplant care, including immunosuppression management, medical and surgical innovation, and academic research.
Surgeons in UMMC’s Division of Transplantation are hand-picked for their skill in applying the newest, least invasive surgeries. UMMC became only the 3rd hospital in the country to adopt single-incision laparoscopic donor nephrectomy as the standard of care for living kidney donors. The donor kidney is removed through a single, small incision in the belly button, and the donor leaves the operating room with a small Band-aid. The surgery is virtually scarless.
UMMC offers adult living donor liver transplants to help patients get transplanted sooner. Surgeons were specifically recruited for this living donor surgery as a response to the shortage of deceased donor organs. Living donor liver transplantation is a highly complex operation that requires skilled surgeons to remove 50-60% of a living donor’s liver and transplant it into a recipient. Unlike living kidney donors who can donate to strangers, living liver donors are encouraged to have a close, personal relationship with the intended recipient. The full spectrum of liver diseases is treated in partnership with the University of Maryland Liver Center.
Cardiothoracic surgeons within the lung transplant program were the first in the U.S. to enroll a patient in a clinical trial to restore damaged donor lungs to high transplantation standards on an “ex vivo” (outside the body) breathing machine, potentially increasing the number of organs viable for transplant by revitalizing lungs that may previously have been passed over for transplantation. This ex vivo revitalization process may also make it possible for donor lungs to be sent to needy recipients farther away where they can then be restored to high transplantation standards at the recipient location within the short window of time after donor death.
As transplant wait lists grow longer across organ types, surgeons at the University of Maryland continue to work tirelessly to increase the number of organs available for transplant. Whether through clinical trials that restore organs from deceased donors to high transplantation standards or through surgical techniques that make living donation less intimidating, the Division of Transplantation at the University of Maryland is committed to helping patients get the new lease on life that they deserve.
This page was last updated: October 27, 2014